In the BioHarmony Drug Report Database

"Preview" Icon

Glycopyrrolate

Cuvposa, Glyrx-pf, Lonhala Magnair, Robinul, Robinul Forte, Seebri (glycopyrrolate) is a small molecule pharmaceutical. Glycopyrrolate was first approved as Cuvposa on 1982-01-01. It is used to treat drug-induced abnormalities, peptic ulcer, and respiratory tract diseases in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M3, and muscarinic acetylcholine receptor M2. Robinul’s patents are valid until 2036-12-07 (FDA).

 

Trade Name

 

Cuvposa, Glyrx-pf, Lonhala Magnair, Robinul, Robinul Forte, Seebri
 

Common Name

 

glycopyrrolate
 

ChEMBL ID

 

CHEMBL1201027
 

Indication

 

drug-induced abnormalities, peptic ulcer, respiratory tract diseases
 

Drug Class

 

Image (chem structure or protein)

Glycopyrrolate structure rendering